09:44 AM EDT, 09/05/2024 (MT Newswires) -- Abbott Laboratories ( ABT ) said Thursday that its first continuous glucose monitoring system that does not require a prescription is available in the US.
The system, Lingo, has a biosensor and a mobile app and is based on Abbott's FreeStyle Libre glucose monitoring technology, the company said.
Price: 113.38, Change: -1.02, Percent Change: -0.89